Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:51:52.148Z.
Calculation as of: 2026-10-06T14:51:52.148Z.
Quote observation: 2026-10-06T14:50:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d443e069440aa0ac5a32f25afa0d38c48efe58a411ec60778b8439bb1c5cf92a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Eledon Pharmaceuticals, Inc.
Market Cap
$191.04M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$190.35M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.94M
Operating Cash Flow Yield
N/A
TTM Avg
4.81%
3Y Avg
4.81%
5Y Avg
4.81%
Market Cap
$180.08M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$202.37M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$178.89M
Operating Cash Flow Yield
N/A
TTM Avg
11.12%
3Y Avg
9.89%
5Y Avg
9.89%
Market Cap
$173.70M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.59M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.45M
Operating Cash Flow Yield
N/A
TTM Avg
13.87%
3Y Avg
13.87%
5Y Avg
13.87%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $191.04M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $190.35M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.94M | N/A | 4.81% | 4.81% | 4.81% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.08M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $202.37M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $178.89M | N/A | 11.12% | 9.89% | 9.89% |
| Cue Biopharma, Inc. (CUE)vs › | $173.70M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $173.59M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $172.45M | N/A | 13.87% | 13.87% | 13.87% |
| Alector, Inc. (ALEC)vs › | $211.50M | N/A | 41.63% | 41.53% | 35.39% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
